Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Suzhou MedicalSystem Technology Co Ltd (603990)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9.85 -0.16    -1.60%
08:00:00 - Closed. Currency in CNY ( Disclaimer )
  • Volume: 5,243,189
  • Bid/Ask: 9.84 / 9.85
  • Day's Range: 9.84 - 10.10
Type:  Equity
Market:  China
ISIN:  CNE100002ZY8 
Suzhou MedicalSystem Tech 9.85 -0.16 -1.60%

Suzhou MedicalSystem Tech Company Profile

 
Read the Suzhou MedicalSystem Technology Co Ltd company profile to learn more about the business and the management team. View Suzhou MedicalSystem Technology Co Ltd facts about employee data, company products and services, and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

723

Equity Type

ORD

Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive auxiliary diagnosis clinical information system that mines and scientifically analyzes for ICU patients’ treatment data with medical information, such as patients’ treatment information, inspection information, nursing information, and doctor's advice data. In addition, it offers DoCare operative medical behavior management system that establishes the intelligent management system for the operation resources and personnel behavior; and DoCare emergency clinical information system for management of emergency clinical, including pre-hospital first aid, pre-examination and triage, emergency rescue, emergency under observation, emergency operating room, emergency ICU, and patient outcome. Further, the company provides DoCare pre-hospital first aid clinical information system that provides a unified service platform, which has digital information for emergency command center, emergency doctors, emergency nurses, visiting medical personnel, and patients. Additionally, it offers smart OT, ICU, and emergency solutions; and smart specialty solutions, such as laminar airflow room, clinical pathway, and mobile nursing information systems, as well as central sterile supply department management systems. The company was founded in 2005 and is based in Suzhou, China.

Contact Information

Address No. 222 Guijia Lane Suzhou Industrial Park
Suzhou, 215021
China
Phone 86 512 6262 1268
Fax 86 512 6262 1268

Top Executives

Name Age Since Title
Min Chen 46 2023 Independent Director
Jiang Jun 40 2023 Supervisor
Dong Li 61 2023 Independent Director
Biao Li 37 2022 Supervisory Board Chairman
Weng Kang 56 2023 Vice Chairman & Joint GM
Ning Chen 44 2022 Chairman
Jianghua Wang 46 - Director & Deputy GM
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

603990 Price Commentary

Write your thoughts about Suzhou MedicalSystem Technology Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email